Single-cell transcriptomic atlas of enteroendocrine cells along the murine gastrointestinal tract

PLoS One. 2024 Oct 8;19(10):e0308942. doi: 10.1371/journal.pone.0308942. eCollection 2024.

Abstract

Background: Enteroendocrine cells (EECs) produce over 20 gut hormones which contribute to intestinal physiology, nutrient metabolism and the regulation of food intake. The objective of this study was to generate a comprehensive transcriptomic map of mouse EECs from the stomach to the rectum.

Methods: EECs were purified by flow-cytometry from the stomach, upper small intestine, lower small intestine, caecum and large intestine of NeuroD1-Cre mice, and analysed by single cell RNA sequencing. Regional datasets were analysed bioinformatically and combined into a large cluster map. Findings were validated by L-cell calcium imaging and measurements of CCK secretion in vitro.

Results: 20,006 EECs across the full gastrointestinal tract could be subdivided based on their full transcriptome into 10 major clusters, each exhibiting a different pattern of gut hormone expression. EECs from the stomach were largely distinct from those found more distally, even when expressing the same hormone. Cell clustering was also observed when performed only using genes related to GPCR cell signalling, revealing GPCRs predominating in different EEC populations. Mc4r was expressed in 55% of Cck-expressing cells in the upper small intestine, where MC4R agonism was found to stimulate CCK release in primary cultures. Many individual EECs expressed more than one hormone as well as machinery for activation by multiple nutrients, which was supported by the finding that the majority of L-cells exhibited calcium responses to multiple stimuli.

Conclusions: This comprehensive transcriptomic map of mouse EECs reveals patterns of GPCR and hormone co-expression that should be helpful in predicting the effects of nutritional and pharmacological stimuli on EECs from different regions of the gut. The finding that MC4R agonism stimulates CCK secretion adds to our understanding of the melanocortin system.

MeSH terms

  • Animals
  • Cholecystokinin / genetics
  • Cholecystokinin / metabolism
  • Enteroendocrine Cells* / metabolism
  • Gastrointestinal Tract* / cytology
  • Gastrointestinal Tract* / metabolism
  • Gene Expression Profiling
  • Male
  • Mice
  • Single-Cell Analysis*
  • Transcriptome*

Substances

  • Cholecystokinin

Grants and funding

All funding for the study was provided from the following sources: Wellcome Trust (220271/Z/20/Z); Medical Research Council (MRC_MC_UU_12012/3); the MS instrument was funded by the MRC “Enhancing UK clinical research” grant (MR/M009041/1); MRL Genomics and Transcriptomics Core, Disease Model Core and Peptidomics Core, supported by MRC (MRC_MC_UU_12012/5); REF was funded by a BBSRC-iCASE studentship partnered with LGC. LGC provided support in the form of partial salary support for REF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the ‘author contributions’ section. There was no additional external funding received for this study. After completing the study, REF moved to work at AstraZeneca. AstraZeneca had no involvement with this study.